Pivotal bioVenture Partners Investment Advisor LLC Long-Term Concentrated

CIK: 0001844645 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 13, 2025

Total Value ($000): $172,984 (100.0% shares, 0.0% debt)

Holdings (10)

PCVX VAXCYTE INC 28.6%
Value ($000) $49,435 Shares 1,372,425 Est. Cost $38.62 Unrealized -14.2%
OCS OCULIS HOLDING AG 23.4%
Value ($000) $40,448 Shares 2,300,774 Est. Cost $12.64 Unrealized +40.3%
ARQT ARCUTIS BIOTHERAPEUTICS INC 23.1%
Value ($000) $39,972 Shares 2,120,508 Est. Cost $11.27 Unrealized +40.0%
ZBIO ZENAS BIOPHARMA INC 10.0%
Value ($000) $17,295 Shares 779,045 Est. Cost $17.27 Unrealized -5.7%
TRVI TREVI THERAPEUTICS INC 6.6%
Value ($000) $11,500 Shares 1,256,782 Est. Cost $6.33 Unrealized +18.4%
IMNM IMMUNOME INC 3.4%
Value ($000) $5,884 Shares 502,512 Est. Cost $9.95 Unrealized 0.0%
BIOA BIOAGE LABS INC 2.2%
Value ($000) $3,842 Shares 653,374 Est. Cost $19.50 Unrealized -76.0%
RXRX RECURSION PHARMACEUTICALS IN 1.7%
Value ($000) $2,906 Shares 595,518 Est. Cost $6.72 Unrealized -21.9%
— RALLYBIO CORP 0.7%
Value ($000) $1,200 Shares 2,404,644 Est. Cost $16.97 Unrealized —
BOLT BOLT BIOTHERAPEUTICS INC 0.3%
Value ($000) $503 Shares 94,573 Est. Cost $6.62 Unrealized -16.2%